Characteristics | FIRS group (n = 48) | Non-FIRS group (n = 66) | P value | ||
---|---|---|---|---|---|
Maternal characteristics | |||||
Maternal age, years, mean ± SD | 31.2 | ± 5.5 | 31.1 | ± 5.7 | 0.93 |
Latency perioda, hours, median, IQR | 23 | 4–51 | 26 | 11–59 | 0.12 |
Gestational diabetes, n, % | 10 | 21 | 13 | 20 | 0.91 |
Group B streptococcus test positive, n, % | 7 | 24 | 10 | 22 | 0.81 |
Primigravida, n, % | 17 | 46 | 31 | 40 | 0.57 |
Primiparous, n, % | 20 | 39 | 28 | 44 | 0.57 |
Gestational age at PPROM, weeks, median, IQR | 31 | 27–33 | 33 | 32–34 | 0.001 |
Tocolytics, n, % | 23 | 48 | 38 | 58 | 0.31 |
Administration of antibiotics, n, % | 48 | 100 | 66 | 100 | 0.45 |
Antenatal glucocorticosteroids, n, % | 41 | 85 | 55 | 83 | 0.76 |
Mode of delivery, n, % | |||||
vaginal delivery | 43 | 90 | 55 | 83 | 0.42 |
cesarean section | 5 | 10 | 11 | 17 | |
Induction of delivery or cesarean section n, % | 17 | 35 | 33 | 50 | 0.28 |
Spontaneous delivery n, % | 31 | 65 | 33 | 50 | |
Cause of initiating delivery, n, % | |||||
Elevating maternal blood biomarkersb | 10 | 58 | 9 | 27 | 0.13 |
≥ 34 weeks of gestation | 2 | 12 | 7 | 21 | |
Prolonged latency period (> 7 days) | 2 | 12 | 3 | 9 | |
Maternal condition | 1 | 6 | 10 | 30 | |
Worsening fetal condition | 2 | 12 | 3 | 9 | |
Umbilical cord prolapse | 0 | 0 | 1 | 3 | |
Clinical chorioamnionitis, n, % | 6 | 13 | 1 | 2 | 0.02 |
Histological chorioamnionitis, n, % | 38 | 79 | 15 | 23 | < 0.001 |
Funisitis, n, % | 21 | 44 | 0 | - | < 0.001 |
Neonatal characteristics | |||||
Gestational age at birth, weeks, median, IQR | 31 | 27–33 | 33 | 32–34 | 0.001 |
Birthweight, grams, mean ± SD | 1688 | ± 669 | 2070 | ± 555 | 0.01 |
Apgar scores < 7 at 1 min., n, % | 14 | 29 | 6 | 9 | 0.01 |
Apgar scores < 7 at 5 min., n, % | 6 | 13 | 1 | 2 | 0.04 |
Umbilical cord arterial pH, Median, IQR | 7.35 | 7.29–7.42 | 7.36 | 7.32–7.40 | 0.77 |
Major outcomec, n, % | 19 | 40 | 11 | 17 | 0.01 |
Respiratory distress, n, % | 46 | 96 | 48 | 73 | 0.001 |
Severe respiratory distress syndromed, n, % | 10 | 21 | 8 | 12 | 0.01 |
Respiratory support, n, % | |||||
None | 2 | 4 | 18 | 27 | 0.01 |
Mechanical ventilation | 11 | 23 | 6 | 9 | |
Noninvasive respiratory therapy | 35 | 73 | 42 | 64 | |
Neonatal death, n, % | 1 | 2 | 0 | - | 0.42 |
Sepsis, n % | 8 | 17 | 2 | 3 | 0.02 |
Early-onset sepsis | 7 | 17 | 1 | 2 | 0.01 |
Bronchopulmonary dysplasia, n, % | 9 | 19 | 4 | 6 | 0.04 |
Open ductus arteriosus, n % | 8 | 17 | 8 | 12 | 0.46 |
Retinopathy of prematurity | 15 | 32 | 6 | 9 | 0.01 |
Intraventricular hemorrhage, n, % | |||||
None | 29 | 60 | 46 | 70 | 0.24 |
1–2 grade | 14 | 29 | 18 | 27 | |
3–4 grade | 5 | 10 | 2 | 3 |